Feng Xu Selected Research

Drug Therapy (Chemotherapy)

5/2024	Stimuli-Responsive Aptamer-Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release.
12/2023	The post-chemotherapy changes of tumor physical microenvironment: Targeting extracellular matrix to address chemoresistance.
11/2023	A New Strategy to Elevate Absorptivity of AIEgens for Intensified NIR-II Emission and Synergized Multimodality Therapy.
8/2023	Thermo-Chemical Resistance to Combination Therapy of Glioma Depends on Cellular Energy Level.
5/2023	Radiation‑induced pure red cell aplasia combined with acquired amegakaryocytic thrombocytopenia in a thymoma after rapid response to radiotherapy: A case report and literature review.
1/2023	Awakening Allies for Breaking Microenvironment Barriers: NIR-II Guided Orthogonal Activation of Tumor-Infiltrating Mast Cells for Efficient Nano-Drug Delivery.
1/2023	Effect of Daratumumab combined with Chemotherapy on Immune Function in Patients with Relapsed/Refractory Multiple Myeloma and Observation of its Clinical Efficacy.
1/2023	Combination Therapy of Lox Inhibitor and Stimuli-Responsive Drug for Mechanochemically Synergistic Breast Cancer Treatment.
12/2022	Apatinib in the treatment of gastric cancer in Henan Province: a multicenter prospective real-world observational study (Ahead-HAP01).
12/2022	Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Xu Research Topics

Disease

334	Neoplasms (Cancer) 05/2024 - 06/2002
94	Inflammation (Inflammations) 04/2024 - 01/2006
56	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2007
53	Infections 01/2024 - 05/2003
44	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2004
37	Lung Neoplasms (Lung Cancer) 04/2024 - 12/2003
33	Fibrosis (Cirrhosis) 01/2024 - 01/2013
33	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 08/2010
32	Type 2 Diabetes Mellitus (MODY) 01/2024 - 10/2008
29	Lung Injury 07/2024 - 09/2003
29	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 09/2002
28	Myocardial Infarction 04/2024 - 06/2007
28	Hyperoxia 04/2019 - 10/2004
27	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 06/2006
26	Sepsis (Septicemia) 02/2024 - 12/2016
26	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 02/2010
25	Wounds and Injuries (Trauma) 01/2024 - 12/2007
25	Reperfusion Injury 10/2023 - 03/2006
25	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 11/2009
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2006
24	Stomach Neoplasms (Stomach Cancer) 05/2024 - 12/2007
24	Pain (Aches) 03/2024 - 10/2007
23	Carcinogenesis 02/2024 - 10/2007
23	Hemorrhage 01/2024 - 09/2007
21	COVID-19 04/2024 - 01/2020
19	Hypertension (High Blood Pressure) 05/2024 - 09/2008
19	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024 - 11/2002
19	Insulin Resistance 01/2024 - 01/2014
19	Carcinoma (Carcinomatosis) 01/2023 - 06/2006
18	Hypoxia (Hypoxemia) 03/2024 - 01/2012
18	Neuroinflammatory Diseases 12/2023 - 07/2005
18	Body Weight (Weight, Body) 01/2023 - 11/2002
18	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 05/2003
17	Pneumonia (Pneumonitis) 01/2024 - 01/2008
17	Ischemia 01/2021 - 10/2012
16	Proteinuria 05/2024 - 08/2010
16	Obesity 03/2024 - 09/2008
16	Thrombosis (Thrombus) 11/2022 - 09/2007
14	Atherosclerosis 05/2024 - 05/2009
14	Critical Illness (Critically Ill) 05/2023 - 01/2011
14	Cognitive Dysfunction 01/2023 - 03/2007
14	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2013
13	Glioma (Gliomas) 05/2024 - 11/2007
13	ST Elevation Myocardial Infarction 05/2023 - 09/2011
13	Aneurysm (Aneurysms) 01/2023 - 10/2010
13	Infarction (Infarctions) 01/2022 - 01/2013
12	Heart Arrest (Cardiac Arrest) 03/2024 - 01/2019
12	Cerebral Hemorrhage 12/2023 - 12/2005
12	Stroke (Strokes) 10/2023 - 01/2018
12	Disease Progression 02/2023 - 12/2011
12	Necrosis 01/2023 - 05/2013
11	Acute Lung Injury 03/2024 - 11/2009
11	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 08/2012

Drug/Important Bio-Agent (IBA)

129	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2002
65	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2009
41	Messenger RNA (mRNA)IBA 01/2024 - 10/2004
38	MicroRNAs (MicroRNA)IBA 01/2023 - 12/2010
37	CytokinesIBA 01/2023 - 08/2005
29	EnzymesIBA 04/2024 - 09/2003
25	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2013
25	Oxygen (Dioxygen)IBA 12/2022 - 08/2006
24	Amyloid (Amyloid Fibrils)IBA 04/2024 - 07/2005
22	Long Noncoding RNAIBA 01/2023 - 07/2014
21	RNA (Ribonucleic Acid)IBA 05/2024 - 06/2014
21	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 08/2010
18	Aldehyde DehydrogenaseIBA 02/2024 - 09/2011
17	Insulin (Novolin)FDA Link 04/2024 - 12/2010
17	Therapeutic UsesIBA 01/2023 - 03/2003
16	CreatinineIBA 05/2024 - 01/2014
16	LipopolysaccharidesIBA 03/2024 - 01/2016
16	LipidsIBA 01/2023 - 11/2006
14	Peptides (Polypeptides)IBA 07/2024 - 04/2009
14	CollagenIBA 11/2023 - 10/2012
14	InterferonsIBA 09/2023 - 05/2011
13	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2013
13	HydrogelsIBA 03/2024 - 04/2013
13	AntigensIBA 02/2024 - 05/2010
13	AlbuminsIBA 01/2024 - 11/2013
13	Indicators and Reagents (Reagents)IBA 04/2023 - 12/2007
12	Blood Glucose (Blood Sugar)IBA 09/2023 - 11/2006
12	Interleukin-6 (Interleukin 6)IBA 08/2023 - 11/2009
12	salicylhydroxamic acid (SHAM)IBA 01/2023 - 06/2010
12	Phosphotransferases (Kinase)IBA 01/2023 - 07/2014
12	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2011
11	CholesterolIBA 05/2024 - 05/2009
11	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 03/2008
11	InflammasomesIBA 02/2024 - 10/2017
11	Hormones (Hormone)IBA 01/2024 - 11/2016
11	AntioxidantsIBA 03/2023 - 10/2008
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2012

Therapy/Procedure

168	Therapeutics 05/2024 - 05/2003
60	Drug Therapy (Chemotherapy) 05/2024 - 10/2005
38	Radiotherapy 10/2023 - 12/2003
32	Immunotherapy 01/2024 - 04/2004
22	Percutaneous Coronary Intervention 05/2023 - 06/2007
17	Stents 08/2023 - 04/2011
14	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2024 - 06/2013
14	Transplantation 06/2023 - 10/2005
11	Ligation 01/2024 - 12/2007
11	Aftercare (After-Treatment) 01/2024 - 11/2013